ArticlePharmaceutics2025

Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors.

Yujie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.